Genetic manipulation and targeted protein degradation in mammalian systems: practical considerations, tips and tricks for discovery research
FEBS Open Bio · 2023
DOI: 10.1002/2211-5463.13581 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift FEBS Open Bio, 2023. Verfasst von Stefano L Giandomenico und 1 weiteren Autor:innen. Beteiligte Einrichtung: Max Planck Institute for Brain Research, Frankfurt am Main, Germany. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Pluripotent Stem Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Federation of European Biochemical Societies, H2020 European Research Council.
Abstract (Originalsprache)
Gaining a mechanistic understanding of the molecular pathways underpinning cellular and organismal physiology invariably relies on the perturbation of an experimental system to infer causality. This can be achieved either by genetic manipulation or by pharmacological treatment. Generally, the former approach is applicable to a wider range of targets, is more precise, and can address more nuanced functional aspects. Despite such apparent advantages, genetic manipulation (i.e., knock‐down, knock‐out, mutation, and tagging) in mammalian systems can be challenging due to problems with delivery, low rates of homologous recombination, and epigenetic silencing. The advent of CRISPR‐Cas9 in combination with the development of robust differentiation protocols that can efficiently generate a variety of different cell types in vitro has accelerated our ability to probe gene function in a more physiological setting. Often, the main obstacle in this path of enquiry is to achieve the desired genetic modification. In this short review, we will focus on gene perturbation in mammalian cells and how editing and differentiation of pluripotent stem cells can complement more traditional approaches. Additionally, we introduce novel targeted protein degradation approaches as an alternative to DNA/RNA‐based manipulation. Our aim is to present a broad overview of recent approaches and in vitro systems to study mammalian cell biology. Due to space limitations, we limit ourselves to providing the inexperienced reader with a conceptual framework on how to use these tools, and for more in‐depth information, we will provide specific references throughout.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Max Planck Institute for Brain Research, Frankfurt am Main, Germany.
ORCID-Profile: Stefano L Giandomenico
Förderung
- Deutsche Forschungsgemeinschaft
- Federation of European Biochemical Societies
- H2020 European Research Council
- Hessisches Ministerium für Wissenschaft und Kunst
- Max Planck Society for the Advancement of Science
Zitieren
APA
Giandomenico, S. L., & Schuman, E. M. (2023). Genetic manipulation and targeted protein degradation in mammalian systems: practical considerations, tips and tricks for discovery research. FEBS Open Bio. https://doi.org/10.1002/2211-5463.13581
Vancouver
Giandomenico SL, Schuman EM. Genetic manipulation and targeted protein degradation in mammalian systems: practical considerations, tips and tricks for discovery research. FEBS Open Bio. 2023. doi:10.1002/2211-5463.13581
BibTeX
@article{Giandomenico2023,
author = {Giandomenico, Stefano L and Schuman, Erin M},
title = {Genetic manipulation and targeted protein degradation in mammalian systems: practical considerations, tips and tricks for discovery research},
journal = {FEBS Open Bio},
year = {2023},
doi = {10.1002/2211-5463.13581}
}
EUVIMED